According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

Tom Castaneda from South Texas Health Systems discusses Sleep apnea on the upcoming episode of STHS TV on NBC 23. This ...

KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision ...

Stifel analysts adjusted their outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target to $190 from the previous $200 while maintaining a Hold rating on the stock. The revision ...

Medicare covers sleep tests for certain conditions such as sleep apnea, narcolepsy, or parasomnia, but limitations may apply.

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

Would you please address the dangers of untreated sleep apnea? Also, what do people do when they are unable to tolerate a CPAP (continuous positive airway pressure) ...

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

Sleep apnea is a disorder that happens when your breathing is disrupted while you sleep. The condition affects sleep quality -- and it can also affect your pocketbook. An analysis by the American ...

Upper airway stimulation therapy is a new sleep apnea treatment. It’s also called hypoglossus nerve stimulation. Your doctor will put three small devices in your chest during surgery to track ...

Inspire is dedicated to developing and commercializing minimally invasive solutions for patients suffering from obstructive sleep apnea. Disclaimer: This is an AI-generated summary of a press ...